Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Empire State Realty Trust
ESRT
$836M
| $677K | ﹤0.01% |
96,855
+1,520
| +2% | +$11.7K |
|
|
HBI
3052
PUT
DELISTED
Hanesbrands
HBI
| $676K | ﹤0.01% |
59,900
-66,700
| -53% | -$667K |
|
3053
Par Pacific Holdings
PARR
$3.32B
| $676K | ﹤0.01% |
75,195
+12,710
| +20% | +$109K |
|
|
GBT
3054
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $675K | ﹤0.01% |
10,699
-85,008
| -89% | -$5.83M |
|
3055
iShares Currency Hedged MSCI Japan ETF
HEWJ
$744M
| $674K | ﹤0.01% |
21,933
| – | – |
|
3056
Children's Place
PLCE
$59.8M
| $674K | ﹤0.01% |
17,995
-16,937
| -48% | -$576K |
|
|
MDP
3057
DELISTED
Meredith Corporation
MDP
| $672K | ﹤0.01% |
46,124
+15,327
| +50% | +$223K |
|
3058
ImmunityBio
IBRX
$8.1B
| $670K | ﹤0.01% |
54,556
+54,516
| +136,290% | +$308K |
|
3059
NRC Health Common Stock
NRC
$450M
| $669K | ﹤0.01% |
11,495
+5,938
| +107% | +$314K |
|
3060
Kadant
KAI
$3.99B
| $667K | ﹤0.01% |
6,690
+2,639
| +65% | +$235K |
|
3061
E.W. Scripps
SSP
$304M
| $667K | ﹤0.01% |
76,395
+7,905
| +12% | +$63.4K |
|
3062
Griffon
GFF
$4.86B
| $666K | ﹤0.01% |
35,851
-3,636
| -9% | -$59.2K |
|
3063
Columbus McKinnon
CMCO
$584M
| $665K | ﹤0.01% |
19,868
+12,208
| +159% | +$337K |
|
3064
York Water
YORW
$514M
| $665K | ﹤0.01% |
13,828
+8,719
| +171% | +$378K |
|
3065
CALL
Delek US
DK
$3.58B
| $663K | ﹤0.01% |
38,100
-5,400
| -12% | -$103K |
|
3066
Northrim BanCorp
NRIM
$587M
| $663K | ﹤0.01% |
105,464
+52,000
| +97% | +$302K |
|
3067
Orion
OEC
$409M
| $663K | ﹤0.01% |
62,612
+9,483
| +18% | +$87.6K |
|
3068
CALL
Devon Energy
DVN
$47.3B
| $662K | ﹤0.01% |
58,400
-125,700
| -68% | -$1.43M |
|
|
INFN
3069
DELISTED
Infinera Corporation Common Stock
INFN
| $660K | ﹤0.01% |
111,401
-36,965
| -25% | -$203K |
|
|
MRSN
3070
DELISTED
Mersana Therapeutics
MRSN
| $659K | ﹤0.01% |
1,126
+88
| +8% | +$30.1K |
|
|
EGRX
3071
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $659K | ﹤0.01% |
13,746
-24,351
| -64% | -$1.21M |
|
3072
Pitney Bowes
PBI
$2.39B
| $657K | ﹤0.01% |
252,936
-9,449
| -4% | -$23.6K |
|
3073
Acco Brands
ACCO
$407M
| $656K | ﹤0.01% |
92,406
+27,363
| +42% | +$170K |
|
3074
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
| $656K | ﹤0.01% |
17,100
-139,100
| -89% | -$5.09M |
|
|
RCM
3075
DELISTED
R1 RCM Inc. Common Stock
RCM
| $656K | ﹤0.01% |
58,790
+23,956
| +69% | +$246K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.